Medical Radiology and Radiation Safety. 2024. Vol. 69. № 1
DOI:10.33266/1024-6177-2024-69-1-77-82
A. Shkuratov1, S. Golub1, 2, Y. Kirpichev1, A. Moiseev1, 3, I. Korovin1, A. Kryaneva1
Water Bolus Utilization for the Radiation Therapy of Patients
with Isolated Superficial Lesions of Cutaneous T-Cell Lymphoma
1 «Medscan» LLC, Moscow, Russia
2 «Peoples’ Friendship University of Russia», Moscow, Russia
3 «RT 7» LLC, Moscow, Russia
Contact person: A.V. Shkuratov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To demonstrate the effectiveness of water bolus, combined with individual immobilization for the treatment of lesions in the pedal region of the foot on a patient with isolated cutaneous T-cell lymphoma lesions.
Material and methods: Construction of individual immobilization devices, simultaneously functioning as a bolus, in two clinical cases of T-cell cutaneous lymphoma radiation therapy in the pedal region of the foot, along with 3D-CRT and VMAT treatment planning, accompanied by retrospective evaluation of interfractional motion.
Results: The proposed methodology demonstrates the effectiveness of the individual immobilization devices in minimizing interfractional motion, as well as the benefit of the bolus effect of the device in achieving optimal dose distribution in the treatment of superficial T-cell lymphoma lesions.
Keywords: radiation therapy, immobilization, bolus, dose evaluation, cutaneous T-cell lymphoma
For citation: Shkuratov A, Golub S, Kirpichev Y, Moiseev A, Korovin I, Kryaneva A.Water Bolus Utilization for the Radiation Therapy of Patients with Isolated Superficial Lesions of Cutaneous T-Cell Lymphoma. Medical Radiology and Radiation Safety. 2024;69(1):77–82. (In Russian). DOI:10.33266/1024-6177-2024-69-1-77-82
References
1. Taylor E.J. Dorland›s Illustrated Medical Dictionary. Philadelphia, Saunders, 2000. P. 1038. ISBN 0721662544.
2. Matasar M.J., Zelenetz A.D.. Overview of Lymphoma Diagnosis and Management. Radiol. Clin. North. Am. 2008;46;2:175-198. DOI: 10.1016/j.rcl.2008.03.005.
3. Armitage J.O., Gascoyne R.D., Lunning M.A., et al. Non-Hodgkin Lymphoma. The Lancet. 2017;390;10091:298–310. DOI:10.1016/s0140-6736(16)3240.
4. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36:1720–1748. DOI:10.1038/s41375-022-01620-2.
5. Клинические рекомендации по диагностике и лечению первичных кожных лимфом. Национальное Гематологическое Общество Российское Профессиональное Общество Онкогематологов, 2014. [Klinicheskiye Rekomendatsii po Diagnostike i Lecheniyu Pervichnykh Kozhnykh Limfom = Clinical Guidelines for the Diagnosis and Treatment of Primary Cutaneous Lymphomas. National Hematological Society Russian Professional Society of Oncohematologists, 2014 (In Russ.)].
6. Streilein J.W. Lymphocyte Traffic. T-Cell Malignancies and the Skin. J. Invest. Dermatol. 1978;71;3:167–171.
7. Joly P., Vasseur E., Esteve E., et al. Primary Cutaneous Medium and Large Cell Lymphomas Other than Mycosis Fungoides. An Immunohistological and Follow-Up Study on 54 Cases. Br. J. Dermatol. 1995;132;4:506–510.
8. James W.D., et al. Andrews’ Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. 2020. ISBNs: 9780323547536, 9780323547543.
9. Korgavkar K., Xiong M., Weinstock M. Changing Incidence Trends of Cutaneous Tcell Lymphoma. JAMA Dermatol. 2013;149;11:1295–1299.
10. Willemze R., Jaffe E.S., Burg G., et al. WHO-EORTC Classification for Cutaneous Lymphomas. Blood. 2005;105;10:3768–3785.
11. Harvey N.T., Spagnolo D.V., Wood B.A. ‘Could It Be Mycosis Fungoides?’: an Approach to Diagnosing Patch Stage Mycosis Fungoides. Journal of Hematopathology. 2015;8;4:209–223.
12. Hodak E., Amitay-Laish I. “Mycosis Fungoides: A Great Imitator”. Clinics in Dermatology. Great Imıtators ın Dermatology: Part I. 2019;37;3:255–267. DOI:10.1016/j.clindermatol.2019.01.004.
13. Rubio-Gonzalez B., Zain J., Rosen S.T., et al. Clinical Manifestations and Pathogenesis of Cutaneous Lymphomas: Current Status and Future Directions. British Journal of Haematology. 2017;176;1:16–36. DOI:10.1111/bjh.14402.
14. Росcийские клинические рекомендации по диагностике и лечению лимфопролиферативных заболеваний / Под ред. Поддубной И.В., Савченко В.Г. М.: Медиа Медика, 2013. 104 с. ISBN 978-5-905305-07-8. [Rosciyskiye Klinicheskiye Rekomendatsii po Diagnostike i Lecheniyu Limfoproliferativnykh Zabolevaniy = Russian Clinical Guidelines for the Diagnosis and Treatment of Lymphoproliferative Diseases. Ed. Poddubnaya I.V., Savchenko V.G. Moscow, Media Medika Publ., 2013. 104 p. ISBN 978-5-905305-07-8 (In Russ.)].
15. NCCN Clinical Practice Guidelines in Oncology. Primary Cutaneous Lymphoma. Version 2. 2022;2022.
16. Diederen P.V., van Weelden H., Sanders C.J. et al. Narrowband UVB and Psoralen-UVA in the Treatment of Early-Stage Mycosis Fungoides: a Retrospective Study. J. Am. AcadDermatol. 2003;48;2:215–219.
17. Gathers R.C., Scherschun L., Malick F., et al. Narrowband UVB Phototherapy for Early-Stage Mycosis Fungoides. J. Am. AcadDermatol. 2002;47;2:191–197.
18. Ponte P., Serrão V., Apetato M. Efficacy of Narrowband UVB vs. PUVA in Patients with Early-Stage Mycosis Fungoides. J. Eur. Acad. Dermatol. Venereol. 2010;24;6:716–721.
19. Кубанов А.А., Карамова А.Э., Знаменская Л.Ф., Воронцова А.А. Фототерапия грибовидного микоза // Онкогематология. 2019; 14(4): 39–47. [Kubanov A.A., Karamova A.E., Znamenskaya L.F., Vorontsova A.A. Phototherapy of Mycosis Fungoides. Onkogematologiya = Oncohematology. 2019;14;4:39–47 (In Russ.)].
20. Querfeld C., Rosen S.T., Kuzel T.M., et al. Long-Term Follow-up of Patients with Early-Stage Cutaneous T-Cell Lymphoma who Achieved Complete Remission with Psoralen Plus UV-A Monotherapy. Arch Dermatol. 2005;141;3:305–311.
21. Rattanakaemakorn P., Ploydaeng M., Udompanich S., et al. Phototherapy as a Treatment of Early-Stage Mycosis Fungoides and Predictive Factors for Disease Recurrence: A 17-Year Retrospective Study. Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 2021;87;5.
22. The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36:1720–1748. DOI:10.1038/s41375-022-01620-2.
23. Youn H. K., Chow S., Varghese A., et al. Clinical Characteristics and Long-term Outcome of Patients with Generalized Patch and/or Plaque (T2) Mycosis Fungoides. 1999.
24. Butson M., Cheung T., Yu P., et al. Effects on Skin Dose from Unwanted Air Gaps under Bolus in Photon Beam Radiotherapy. Radiation Measurements - RADIAT MEAS. 2000;32:201-204. DOI: 10.1016/S1350-4487(99)00276-0.
25. Демина О.М., Акилов О.Е., Румянцев А.Г. Т-клеточные лимфомы кожи: современные данные патогенеза, кли-ники и терапии // Онкогематология. 2018. Т.13, № 3. С. 25–38. [Demina O.M., Akilov O.E., Rumyantsev A.G. Cutaneous T-Cell Lymphomas: Modern Data of Pathogenesis, Clinics and Therapy. Onkogematologiya = Oncohematology 2018;13;3:25–38 (In Russ.)].
26. Huang K.M., Hsu C.H., Jeng S.C., et al. The Application of Aquaplast Thermoplastic as a Bolus Material in the Radiotherapy of a Patient with Classic Kaposi’s Sarcoma at the Lower Extremity. Anticancer Res. 2006;26;1B:759-762.
27. Muruganandam P., Voruganti S.M., Ostapiak O., et al. Extensive Cutaneous
T-Cell Lymphoma and Challenges with radiation Treatment. Applied Radiation Oncology. 2017:29-32.
28. Majithia L., Rong Y., Siddiqui F., et al. Treating Cutaneous T-Cell Lymphoma with Highly Irregular Surfaces with Photon Irradiation Using Rice as Tissue Compensator. Front. Oncol. 2015;5:49. DOI:10.3389/fonc.2015.00049.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.10.2023. Accepted for publication: 27.11.2023.